GLICLAZIDA 30 MG COM LIB PROL CT BL AL AL X 60

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1235202690033
  • GGREM 529920080067507
  • Código de barras 7897076922397

O que a fonte publica

Detentor do registro
RANBAXY FARMACÊUTICA LTDA
Princípios ativos
GLICLAZIDA
Embalagem
30 MG COM LIB PROL CT BL AL AL X 60
Regime de dispensação
Tarja Vermelha
Tipo de produto
Genérico
Classe terapêutica
A10H - ANTIDIABÉTICOS SULFONILOURÉIAS PUROS
Prescrição
Sob prescrição ou restrito

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:529920080067507
{
  "name": "GLICLAZIDA 30 MG COM LIB PROL CT BL AL AL X 60",
  "holder": "RANBAXY FARMACÊUTICA LTDA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7897076922397"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "529920080067507",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "73.663.650/0001-90",
  "priceRegime": "Regulado",
  "productName": "GLICLAZIDA",
  "productType": "Genérico",
  "hospitalOnly": false,
  "presentation": "30 MG COM LIB PROL CT BL AL AL X 60",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "39.15",
    "icms-12": "44.49",
    "icms-17": "47.17",
    "icms-18": "47.74",
    "icms-19": "48.33",
    "icms-20": "48.94",
    "icms-21": "49.56",
    "icms-22": "50.19",
    "icms-23": "50.84",
    "icms-17.5": "47.45",
    "icms-19.5": "48.63",
    "icms-20.5": "49.25",
    "icms-22.5": "50.52",
    "icms-12-alc": "43.95",
    "icms-17-alc": "46.60",
    "icms-18-alc": "47.17",
    "icms-19-alc": "47.75",
    "icms-20-alc": "48.35",
    "icms-21-alc": "48.96",
    "icms-22-alc": "49.59",
    "icms-23-alc": "50.23",
    "withoutTaxes": "38.68",
    "icms-17.5-alc": "46.89",
    "icms-19.5-alc": "48.05",
    "icms-20.5-alc": "48.65",
    "icms-22.5-alc": "49.91"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "GLICLAZIDA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "53.96",
    "icms-12": "61.32",
    "icms-17": "65.02",
    "icms-18": "65.80",
    "icms-19": "66.62",
    "icms-20": "67.46",
    "icms-21": "68.31",
    "icms-22": "69.18",
    "icms-23": "70.08",
    "icms-17.5": "65.40",
    "icms-19.5": "67.03",
    "icms-20.5": "67.89",
    "icms-22.5": "69.64",
    "icms-12-alc": "60.76",
    "icms-17-alc": "64.42",
    "icms-18-alc": "65.21",
    "icms-19-alc": "66.01",
    "icms-20-alc": "66.84",
    "icms-21-alc": "67.68",
    "icms-22-alc": "68.56",
    "icms-23-alc": "69.44",
    "withoutTaxes": "53.47",
    "icms-17.5-alc": "64.82",
    "icms-19.5-alc": "66.43",
    "icms-20.5-alc": "67.26",
    "icms-22.5-alc": "69.00"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "GLICLAZIDA"
  ],
  "therapeuticClass": "A10H - ANTIDIABÉTICOS SULFONILOURÉIAS PUROS",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1235202690033",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "A10H",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:529920080067507"